General MedicationsORALGeneric
VORTIOXETINE HYDROBROMIDE
VORTIOXETINE HYDROBROMIDE
Standard Dose
EQ 20MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview VORTIOXETINE HYDROBROMIDE is listed in Drugs@FDA under application 211146 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient VORTIOXETINE HYDROBROMIDE Form and strength TABLET;ORAL - EQ 20MG BASE Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2024-04-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview VORTIOXETINE HYDROBROMIDE is listed in Drugs@FDA under application 211146 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient VORTIOXETINE HYDROBROMIDE Form and strength TABLET;ORAL - EQ 20MG BASE Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2024-04-02 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.